Almirall, S.A. (ALM), through its open innovation platform AlmirallShare, is now accepting proposals for translational preclinical models to help fight key skin diseases —such as psoriasis, atopic dermatitis, acne, and rosacea— for the chance to get support from Almirall.
These can be in vitro assays or in vivo models relevant in the context of the disease that have translatable clinical endpoints. All proposals submitted before the deadline of December, 31th, 2017 will be considered for up to €100,000 worth of funding.
After the submissions of their proposals, the Almirall team will review them and suggest the best way for the selected proposals to progress. We are here to help your idea grow, and provide mentorship to help your initial proposal meet project criteria, as well as support along your journey.
The clock is ticking towards the deadline for this first Almirall challenge. We will be glad to collaborate with you.
Don’t let your ideas miss out on a chance to change the lives of people with skin diseases!
AlmirallShare first Scientific call: Preclinical Models Date: from 12/09/17 to 31/12/17 Participants: universities, research entities, biotechs, start-ups, hospitals. Grants: €25.000 to €100.000
For more information, please visit almirall.com
